Effect of calcium dobesilate on nephropathy in type 2 diabetic rats

Abstract

In order to investigate the effects and mechanisms of calcium dobesilate on renal lesions in experimental type 2 diabetic rats, dibetic rats were randomly divided into control group (group C) and experimental group (group D) treated with calcium dobesitate. The serum creatinine (Scr), protein kinase C (PKC), creatinine clearance (Ccr), transforming growth factor-beta₁ (TGF-β₁), type IV collagen were compared among the groups after 24 weeks. The renal tissues were observed under light microscopy and electron microscopy. The results showed that after 24 weeks, Scr, PKC, TGF-β₁ in group D were significantly lower than in group C, meanwhile, renal pathologic changes in group D were improved. Ccr had no difference between group C and group D. It was concluded that calcium dobesilate could ameliorate renal lesions in diabetic rats through inhibiting PKC and TGF-β₁

Keywords

calcium dobesilate / diabetic nephropathy / protein kinase C

References

[1] RivarolaE W, Moyses-NetoM, DantasM, et al.. Transforming growth factor-β1 activity in urine of patients with type 2 diabetes and diabetic nephropathy. Braz J Med Bio Res, 1999, 32(12): 1525-1525

[2] EllisD, ForrestK Y, ErbeyJ, et al.. Urinary measurement of transforming growth factor-β1 and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Clin Chem, 1998, 44: 950-950

[3] YoyaD, KingG L. Protein kinase C activation and development of diabetic complication. J Diabetes, 1998, 47: 859-859

[4] ScivittaroV, GanzM B, WeissM F. AGEs induce oxidative stress and activate protein kinase C-β II in neonatal mesangial cells. Am J Physiol Renal Physiol, 2000, 278: F676-F676

[5] BrunetJ, FarineJ C, GarayR P, et al.. Angioprotective action of calium dobesilate against reactive oxygen species-induced capillary permeability in the rat. Eur J Pharmacol, 1998, 358: 213-213

[6] RotaR, ChivaroliC, GarayR P, et al.. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rat. Eur J Pharmacol, 2004, 495(2–3): 217-217

[7] KoyaD, HanedaM, NakagawaH, et al.. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC-β inhibitor in diabetic db/db mice, a rodent model for type 2 diabeties. FASEB J, 2000, 14: 439-439